Lipella Pharmaceuticals Inc. (LIPO)
NASDAQ: LIPO · Real-Time Price · USD
2.410
-0.080 (-3.21%)
At close: Nov 20, 2024, 4:00 PM
2.550
+0.140 (5.81%)
Pre-market: Nov 21, 2024, 5:49 AM EST

Lipella Pharmaceuticals Revenue

Lipella Pharmaceuticals had revenue of $80.38K in the quarter ending September 30, 2024, a decrease of -22.75%. This brings the company's revenue in the last twelve months to $483.53K, up 0.78% year-over-year. In the year 2023, Lipella Pharmaceuticals had annual revenue of $449.62K with 144.15% growth.

Revenue (ttm)
$483.53K
Revenue Growth
+0.78%
P/S Ratio
4.77
Revenue / Employee
$69,076
Employees
7
Market Cap
2.91M

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 2023449.62K265.46K144.15%
Dec 31, 2022184.16K-75.19K-28.99%
Dec 31, 2021259.35K-702.34K-73.03%
Dec 31, 2020961.68K266.94K38.42%
Dec 31, 2019694.75K--
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.